- Home
- PRTS vs SCLX Comparison
PRTS vs SCLX Comparison
Compare PRTS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- SCLX
- Stock Information
- Founded
- PRTS 1995
- SCLX 2011
- Country
- PRTS United States
- SCLX United States
- Employees
- PRTS N/A
- SCLX N/A
- Industry
- PRTS Auto & Home Supply Stores
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- SCLX Health Care
- Exchange
- PRTS Nasdaq
- SCLX Nasdaq
- Market Cap
- PRTS 40.0M
- SCLX 35.7M
- IPO Year
- PRTS 2007
- SCLX N/A
- Fundamental
- Price
- PRTS $0.64
- SCLX $12.78
- Analyst Decision
- PRTS Hold
- SCLX Buy
- Analyst Count
- PRTS 1
- SCLX 2
- Target Price
- PRTS $0.70
- SCLX $245.00
- AVG Volume (30 Days)
- PRTS 967.9K
- SCLX 294.8K
- Earning Date
- PRTS 10-28-2025
- SCLX 08-13-2025
- Dividend Yield
- PRTS N/A
- SCLX N/A
- EPS Growth
- PRTS N/A
- SCLX N/A
- EPS
- PRTS N/A
- SCLX N/A
- Revenue
- PRTS $577,614,000.00
- SCLX $44,236,000.00
- Revenue This Year
- PRTS N/A
- SCLX $89.26
- Revenue Next Year
- PRTS $2.62
- SCLX $203.95
- P/E Ratio
- PRTS N/A
- SCLX N/A
- Revenue Growth
- PRTS N/A
- SCLX N/A
- 52 Week Low
- PRTS $0.64
- SCLX $3.60
- 52 Week High
- PRTS $1.42
- SCLX $39.90
- Technical
- Relative Strength Index (RSI)
- PRTS 35.74
- SCLX 33.57
- Support Level
- PRTS $0.64
- SCLX $14.80
- Resistance Level
- PRTS $0.70
- SCLX $15.25
- Average True Range (ATR)
- PRTS 0.02
- SCLX 2.44
- MACD
- PRTS -0.00
- SCLX -0.99
- Stochastic Oscillator
- PRTS 1.24
- SCLX 1.60
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.